Covid-19 Research

Review Article

Environmental Health Perspectives on the Emergence and Re-Emergence of Infectious Diseases, Geopolitics and Gain of Function Research

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access
Article Type Review Article
Subject General Science
OCLC 9385830624
Chrysanthus Chukwuma SR*
Issue: Volume2-Issue12
Pages: 1298-1303
Received: 2021-12-17
Accepted: 2021-12-24
Published: 2021-12-29

Abstract

Research and publication are relevant from perspectives in the management of local and global health because disease is perspicuously a geopolitical issue ostensibly linked to gain-of-function research where health diplomacy undergirds present and future global functionalities regarding the emergence and reemergence of infectious diseases. These have generated vehement reactions with propensity for extreme geopolitics and gain-of-function natural and anthropogenic activities. Geopolitical parameters and gain-of-function issues impact on the social determinants of health and vice versa. The convening and convergence of countries for unprecedented epidemic or pandemic treaty settings or other formulations to confront emerging and reemerging infectious diseases will afford considerable opportunities concerning challenges in action, preparedness and response. Provisions are pertinent for legal instruments, effective and efficient systems to curb future threats and outbreaks of infectious diseases.

FullText HTML FullText PDF DOI: 10.37871/jbres1386 Crossmark

Certificate of Publication

Certificate of Publication

Copyright

© 2021 Chrysanthus Chukwuma SR. Distributed under Creative Commons CC-BY 4.0 Creative CommonsAttribution

How to cite this article

Chrysanthus Chukwuma SR. Environmental Health Perspectives on the Emergence and Re-Emergence of Infectious Diseases, Geopolitics and Gain of Function Research. J Biomed Res Environ Sci. 2021 Dec 29; 2(12): 1298-1303. doi: 10.37871/jbres1386, Article ID: JBRES1386, Available at: https://www.jelsciences.com/articles/jbres1386.pdf

Subject area(s)

Community Health

References

  1. Chukwuma Sr C. Bioinformatics-base and determinants in the spatiotemporal variations of emerging and reemerging infectious diseases. Journal of Ancient Diseases & Preventive Remedies. 2018;6(2):182. DOI: 10.4172/2329.8731-1000182.
  2. Vicidomini S. Link between the start of pandemic SARS-CoV/2 (COVID19) and the human seafood wholesale market in wuhan (hubei: china): A first review of bibliographical pre-pandemic evidences. 2021. DOI: 10.13140/RG.2.2.19975.52648.
  3. Chukwuma Sr C. Ecosystem cadastre of plant-soil interactions with nonferrous metals. Int J Curr Res Chem Pharm Sci. 2021;8(6):17-26. DOI: 10.22192/ijcrcps.2021.08.06.003.
  4. Baker RE, Mahmud AS, Miller IF, Rajeev M, Rasambainarivo F, Rice BL. Infectious disease in era of global change. Nat Rev Microbiol. 2021. Doi: 10.1038/s41579-021-00639-z.
  5. Evans TS, Shi Z, Boots M, Liu W, Olival KJ, Xiao X. Synergistic China-US ecological research is essential for global emerging infectious disease preparedness. EcoHealth. 2020;17:160-173. Doi: 10.07/s10393-020-01471-23.
  6. Chukwuma Sr C. Accessing vaccines with compliance to stem the emergence and dissemination of the SARS-CoV-2 or COVID-19 variants. DOI: 10.13140/RG.2.2.28632.62728.
  7. Chukwuma Sr C. Challenges and opportunities in accessing veritable vaccines and curbing the dissemination and excesses of the SARS-CoV-2 or COVID-19 variants. Middle East Publishers Scholars International Journal of Biochemistry. 2021;4(9):108-111. DOI: 10.36348/sijb.2021v04i09.003.
  8. Sabin NS, Calliope AS, Simpson SV. Implications of human activities for (re)emerging infectious diseases, including COVID-19. J Physiol Anthropol. 2020;39:29. Doi: 10.1186/s40101-020-00239-5.
  9. Chukwuma Sr C. Acquired immunodeficiency syndrome in sub-Saharan Africa: Epidemiological, sociological and preventive perspectives. Scandinavian Journal of Development Alternatives. 1996;15(2):74-89.
  10. https://tinyurl.com/3ez3rkc7
  11. Greenwood M. What is gain-of-function research?
  12. https://tinyurl.com/4rpnj3ec
  13. Cele S, Gazy I, Jackson L, Hwa SH, Tegally H, Lustig G, Giandhari J, Pillay S, Wilkinson E, Naidoo Y, Karim F, Ganga Y, Khan K, Bernstein M, Balazs AB, Gosnell BI, Hanekom W, Moosa MS; Network for Genomic Surveillance in South Africa; COMMIT-KZN Team, Lessells RJ, de Oliveira T, Sigal A. Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma. Nature. 2021 May;593(7857):142-146. Doi: 10.1038/s41586-021-03471-w. Epub 2021 Mar 29. PMID: 33780970.
  14. The Economist. Will the COVID-19 pandemic make this year's flu season worse? 2021.
  15. https://tinyurl.com/nhavu5d4
  16. USRTK. How NIH-funded research in China could have led to the COVID-19 pandemic.
  17. https://tinyurl.com/54xx39hn
  18. Chukwuma Sr. Information and communication needs in the administration of ibuprofen in the treatment of symptoms in COVID-19 patients. JMR. 2020;6(4):128-130.
  19. https://tinyurl.com/mr4crb6s
  20. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020;94. DOI: 10.1128/JVI.00127-20.
  21. Fang L, Karakiulakis, Roth M. Are patients with hypertension and diabetes at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8. DOI: 10.1016/52213-2600(20)30116-8.
  22. Day M. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. BMJ. 2020;368: 1086. Doi: 10.1136/bmj.m1086. PMID: 32184201.
  23. Excler JL, Seville M, Berkley S, Kim JH. Vaccine development for emerging infectious diseases. Nat Med. 2021;27:591-600. Doi: 10.1038/s41591-021-01301-o.
  24. Chukwuma Sr C. The impacts of mining operations in Nigeria with particular reference to the Enyigba-Abakaliki area. Int J Env Edu Inf. 2021;12(4):321-336.
  25. https://tinyurl.com/yc6d57jp
  26. Chukwuma Sr C. Information-base and determinants of medical specialization and primary care: A view point. JBAH. 2014;4(8).
  27. https://tinyurl.com/4v42m976
  28. Chukwuma Sr C, Bjurulf P. A case study of the information-base needed for effective evaluation of primary health care programmesin Anambra State, Nigeria. Int J Health Sc. 1990;1(2):137-148.
  29. https://tinyurl.com/4x45jtkw
  30. Chukwuma Sr C. Ecological analysis of the COVID-19 pandemic for restoration and sustainability. Research and Advances in Pharmacy & Life Sciences. 2021;3(1).
  31. Chukwuma Sr C. Defining environmental management and planning policy in Nigeria. Int J Agric Med & Rural Health. 1996;20(1):13-18.
  32. Sawanpanyalert P. Roles of multi-country networking in prevention and control of emerging and re-emerging infections. Trop Med & Health. 2006;34(4):149-152. Doi: 10.2149/tmh.34.1495.
  33. Schwartz DA, Herman CJ. The importance of the autopsy in emerging and reemerging infectious diseases. Clin Infect Dis. 1996 Aug;23(2):248-254. Doi: 10.1093/clinids/23.2.248. PMID: 8842258.
  34. Fidler DP. Germs, governance, and global public health in the wake of SARS. J Clin Invest. 2004 Mar;113(6):799-804. Doi: 10.1172/JCI21328. PMID: 15067309; PMCID: PMC362129.
  35. Mykhalovskiy E, Weir L. The geopolitics of global public health surveillance in the twenty-first century. Medicine at the Border. 2007. Doi: 10.1057/9780230288904_13.
  36. Chukwuma Sr C. Hunger in the COVID-19 pandemic. Int J Adv Res Rev. IJARR. 2020;5(11):20-23.
  37. Raheem D, Chukwuma Sr C. Foods from cassava and their relevance to Nigeria, and other African countries. Agriculture & Human Values. 2001;18(4):383-390. Doi: 10.1023/A:1015233606665.
  38. Chukwuma Sr C. Restoration and sustainability of petroleum-contaminated sites in the human environment. Journal of Clinical Trials and Regulations. 2019;1(1):57-70. Doi: 10.5281/zenodo.2597718.
  39. Dodds K, Cole J. Unhealthy geopolitics : Can the response to COVID-19 reform climate change policy? Bull. World Health Organ. 2021;99(2):148-154. Doi: 10.2471/BLT.20.269068.
  40. Tabor E, Gerety RJ, Cairns J, Bayley AC. Did HIV and HTLV originate in Africa? (letter). JAMA. 1990;264(6):691-692.
  41. Ardoo A. The limits and prospects of AIDS legislation in anglophone Africa. Int Conf AIDS. 1990;5:941.
  42. WHO. Africa unlikely to end AIDS as public health threat by 2030. 2021.
  43. https://tinyurl.com/bd5x4abw
  44. Chukwuma Sr C. Cryptosporidium: Still a public health problem - A review. Niger Med J. 1996;30(1):6-10.
  45. https://tinyurl.com/2p933hm3
  46. Chukwuma Sr C. Cryptosporidium: Public health problems and environmental indicators. Austin Medical Sciences. 2019;4(2):1036.
  47. Chukwuma Sr C. The Clinicopathological correlates of cystoisosporiasis in immunocompetent, immunocompromised and HIV-infected/AIDS patients but neglected in SARS-CoV-2/COVID-19 patients? Int J Clin Microbiol Biochem Technol. 2021;4:001-004. DOI: 10.29328/journal.ijcmbt.1001018.
  48. Chukwuma C Sr. Microsporidium in AIDS patients: A perspective. East Afr Med J. 1996 Jan;73(1):72-75. PMID: 8625869.
  49. Sen M, Honavar SG, Sharma N, Sachdev MS. COVID-19 and Eye: A review of ophthalmic manifestations of COVID-19. Indian J Ophthalmol. 2021 Mar;69(3):488-509. Doi: 10.4103/ijo.IJO_297_21. PMID: 33595463; PMCID: PMC7942063.
  50. Chukwuma Sr C. Explicating the presentations of acanthamoeba keratitis with special concern in the COVID-19 pandemic ambient. IJCMBT. 2021;4:10.
  51. https://tinyurl.com/28vmz74c
  52. Jones L, Walsh K, Willcox M, Morgan P, Nichols J. The COVID-19 pandemic: Important considerations for contact lens practitioners. Cont Lens Anterior Eye. 2020 Jun;43(3):196-203. Doi: 10.1016/j.clae.2020.03.012. Epub 2020 Apr 3. PMID: 32273245; PMCID: PMC7129028.
  53. Chukwuma Sr C. Comments on the environmental health implications of Acanthamoeba. Int J Env Hlth Res. 1996;6(1):49-54. Doi: 10.1080/09603129609356872.
  54. Chukwuma Sr C. Application of global concepts to the Nigerian food crisis. Journal of Agriculture & Related Studies. 1995;31(5):3-9.
  55. https://tinyurl.com/2e7pxtbb
  56. National Academies Press (US). Gain-of-function research. Background and Alternatives. 2021.
  57. https://tinyurl.com/yckzb3pr
  58. News Feature. The shifting sands of ''gain-of-function'' research. Nature. 2021. DOI: 10.1038/d41586-021-02903-x.
  59. Cao C. China's evolving biosafety/biosecurity legislations. J Law Biosci. 2021;8(1). Doi: 10.1093/jlb/lsab020.
  60. Selgelid MJ. Gain-of-function research: Ethical analysis. Sci Eng Ethics. 2016;22(4):923-964. Doi: 10.1007/s11948-016-9810-1.
  61. Chukwuma Sr C. Undergirding environmental legislation and citizen participation in developing countries. Int J Env Edu Inf. 1996;15(3):319-330.
  62. Chukwuma Sr C. Perspectives for a sustainable society. Environ Manage & Health. 1996;7(5):6-20. Doi: 10.1108/09566169610130377.
  63. Chenneville T, Gabbidon K, Hanson P, Holyfield C. The impact of COVID-19 on HIV treatment and research: A call to action. Int J Environ Res Public Health. 2020;17(12):45-48. Doi: 10.3390/ijerph17124548.
  64. Chukwuma Sr C. Accessing vaccines with compliance to stem the emergence and dissemination of the SARS-CoV-2 or COVID-19 variants. Research Trends of Microbiology. MedDocs Publishers LLC. 2021;3(2):12-15.
  65. Morens DM, Fauci AS. Emerging pandemic diseases: How we got to COVID-19. Cell. 2020;182(5):1077-1092. Doi: 10.1016/j.cell.2020.08,021
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership